Effectiveness and Safety of Sofosbuvir-Velpatasvir in Patients with Cirrhosis Associated with Genotype 3 Hepatitis C Infection in Xinjiang, China

PURPOSE: Patients with cirrhosis from genotype 3 (GT3) hepatitis C virus (HCV) infection are difficult to cure. This study investigated the effectiveness and safety of sofosbuvir-velpatasvir (SOF/VEL) with and without ribavirin (RBV) in patients with GT3 HCV-infection-related cirrhosis from Xinjiang...

Descripción completa

Detalles Bibliográficos
Autores principales: Abulitifu, Yilihamu, Lian, Jiangshan, Adilijiang, Munire, Liu, Lan, Zhao, Fengcong, Qian, Wen, Zhang, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639400/
https://www.ncbi.nlm.nih.gov/pubmed/36353379
http://dx.doi.org/10.2147/IDR.S385071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639400/
https://www.ncbi.nlm.nih.gov/pubmed/36353379
http://dx.doi.org/10.2147/IDR.S385071

Ejemplares similares